Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Boutique CRDMO redefining Drug Substance development through its inGenius® platform. With 20+ years of success we develop high-performing mammalian and microbial bioprocesses optimized for productivity, stability, and scale. Leveraging AI across multiple areas, we enhance and streamline development of biologics and complex small molecules.
In this webinar, Dr. Rita Cruz will introduce Ingenza’s inGenius™ platform, which plays a pivotal role in speeding up a candidate’s journey to the clinic.
Released By Ingenza Ltd.
Process development is a crucial stage in biopharmaceutical manufacturing.
Koenig has extensive experience in both neuropsychiatric disorders and neurodegenerative diseases, including Alzheimer’s disease.
By: Patrick Lavery
Strengthens its global commercial organization with three new senior business development appointments.
By: Charlie Sternberg
Salter-Cid’s expertise in immunology and immuno-oncology will be called upon as Harbour expands a pipeline of differentiated antibody therapeutics.
Strengthens its ability to provide a seamless path from DNA to IND submission for its customers.
The expansion adds Denmark, Finland, Norway, and Sweden to 13 markets already covered in the partnership in Southeast Europe.
Aims to support formulation development for poorly soluble and development-challenged small molecule drug candidates.
Rapid growth over the last 12 months has seen the business more than double in size.
The partners seek to define and subsequently develop an allogeneic pancreatic beta cell therapy based on patient needs.
The acquisition adds gamgertamig to Gilead’s inflammation portfolio and will be the foundation of Lakefront’s clinical development pipeline.
Inaugurates new production lines for both standard and sterile ready-to-use (RTU) glass vials.
Why analytical method performance depends not only on sample size, but on a lifecycle-based control strategy that understands uncertainty, variability, and risk.
By: Paul Mason
Aims to boost clinical supply and commercialization readiness for Ratio’s lead radiopharmaceutical therapy.
Margin compression, tariff exposure, and supplier consolidation are piling pressure on contract manufacturers. But single-use technology redrew the competitive landscape and a second wave in cell and gene therapy is doing it again.
By: Dan Stanton
Phase II starts are increasing the fastest of all clinical phases, trials are running leaner, and the safety data challenge is growing.
By: Patrick Hughes
Appoints Dr. Alison D. Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
